London, United Kingdom

Gavin Paul Vinson

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 1.9

ph-index = 3

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2000-2016

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: **Gavin Paul Vinson: A Pioneer in Monoclonal Antibody Innovations**

Introduction

Gavin Paul Vinson is a distinguished inventor based in London, GB, recognized for his contributions to the field of monoclonal antibodies. With a total of 9 patented inventions, Vinson has made significant strides in advancing medical technology and therapeutic applications.

Latest Patents

Among his notable inventions is the patent for a synthetic scFv analogue to the 6313/G2 monoclonal antibody variable regions. This invention focuses on a specific binding molecule that targets a peptide with the amino acid sequence EDGIKRIQDD. The patented technology involves a polypeptide component that integrates an immunoglobulin VL domain linked to an immunoglobulin VH domain, showcasing specific Complementarity Determining Regions (CDRs). Notably, the VL domain comprises CDRs VLCDR1, VLCDR2, and VLCDR3, while the VH domain includes CDRs VHCDR1, VHCDR2, and VHCDR3, each with unique amino acid sequences. Furthermore, the invention emphasizes sequences that hold at least 70% identity to the specified amino acid sequences, enhancing the binding specificity and potential applications of these antibodies in therapeutic interventions.

Career Highlights

Gavin Vinson's career includes significant academic and research positions at prestigious institutions such as Queen Mary & Westfield College and the University of London. His work at these institutions has played a crucial role in his research and the development of innovative antibody technologies, establishing him as a prominent figure in his field.

Collaborations

Throughout his career, Vinson has worked alongside notable colleagues, including Stewart Barker and John Richard Puddefoot. Their collaboration has fostered an environment of innovation and research that has resulted in the development of groundbreaking monoclonal antibody technologies.

Conclusion

Gavin Paul Vinson stands out as an influential inventor whose work in monoclonal antibodies continues to impact medical science. With numerous patents to his name and a strong collaborative network, his inventions pave the way for new therapeutic solutions and advancements in medical research. His contributions reflect the vital interplay between innovation and healthcare, making him a noteworthy figure in the realm of biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…